Masimo today announced its board of directors nominated Christopher Chavez as a Class II director. The nomination follows Rolf Classon’s unexpected resignation on May 10 due to health issues. Chavez has more than 30 years of leadership experience in the medical device industry, including two past roles as a public company CEO and many years […]
Masimo
Masimo recalls some Rad-G pulse oximeters
Masimo recently issued an urgent medical device recall notice for some Rad-G pulse oximeters. The company issued the recall due to certain Rad-G devices powering off and on without pressing the power button. Masimo said the issue can result in an unintentional change in the device’s power state. According to a company warning letter to […]
Masimo is looking at two options to separate consumer business
Masimo announced that its board will consider a number of options to split from its consumer business, undoing a more than $1 billion acquisition from two years ago. “The options being considered, among others, are a spin-off of the consumer business in the form of this new stock issued to existing shareholders as a dividend […]
FDA clears over-the-counter Stork baby monitor from Masimo
Masimo announced today that the FDA cleared its Stork baby monitoring system for over-the-counter use. Stork offers a continuous and accurate view of a baby’s health data. It leverages Masimo’s noninvasive neonate monitoring technologies. Masimo’s smart home baby monitoring system received its initial FDA clearance in December 2023. The company already began its U.S. rollout to […]
Politan picks a new Masimo board fight, targeting CEO’s seat after recent wins
Masimo is fighting with Politan Capital Management again after the activist investor won a heated battle for two seats last year. Politan Managing Partner and Chief Investment Officer Quentin Koffey said his firm is nominating two more candidates for election to the board at this year’s annual meeting in a bid to take control of […]
Masimo looks to separate consumer business two years after $1 billion buyout
Masimo will move forward with a proposal by Chairman and CEO Joe Kiani to separate the medtech developer from its consumer business. Kiani would remain chair and CEO of Irvine, California–based Masimo and serve as chair of the new consumer company, which includes Sound United parent company Viper Holdings that Masimo bought for $1.025 billion […]
Masimo stock dips despite Street-beating Q4
Masimo shares fell slightly despite fourth-quarter results that came in ahead of the consensus forecast. Shares of MASI dipped 2.6% at $126.76 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 0.3%. The Irvine, California–based patient monitoring technology developer posted profits of […]
FDA clears first over-the-counter fingertip pulse oximeter from Masimo
Masimo announced today that it received FDA clearance for its MightySat Medical over-the-counter fingertip pulse oximeter. The company says that the regulatory nod makes MightySat Medical the first and only FDA-cleared medical fingertip pulse oximeter available over the counter (OTC), direct to consumers without a prescription. Irvine, California-based Masimo powers its OTC pulse oximeter with […]
Study says Masimo pulse oximetry is accurate for different skin colors
Masimo today announced findings from a study evaluating its pulse oximetry technology across a variety of skin pigmentations. Dr. Vikrant Sharma, Dr. Steven Barker, Dr. William C. Wilson and colleagues at Masimo performed a focused analysis of previously published data evaluating the impact of low perfusion on the performance of Masimo SET pulse oximetry across […]
Court denies Apple’s watch ban appeal in Masimo patent spat
Bloomberg reports that the U.S. Court of Appeals for the Federal Circuit declined to grant a longer pause on the Apple Watch import ban as a result of patent litigation with Masimo . Shares of MASI were up 2.1% to $122.57 apiece just before the market closed today on the back of the news. The […]
Apple reportedly pulling pulse oximetry from watches if Masimo case appeal fails
Federal customs officials have reportedly approved Apple’s workaround to continue importing Series 9 and Ultra 2 watches if it fails in its appeal of an import ban in its patent dispute with Masimo. The consumer tech giant has told U.S. Customs and Border Protection that redesigned watches “definitively do not contain pulse oximetry functionality,” according […]
